Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 617,344 | 766,358 | 553,074 | 585,448 | 605,755 |
| Marketable Securities | N/A | N/A | N/A | 124,364 | 248,307 |
| Receivables | 110,913 | 31,505 | 7,727 | 8,091 | 7,518 |
| Inventories | 103,216 | 85,484 | 85,714 | 59,753 | 48,451 |
| Other current assets | 26,809 | 34,349 | 36,658 | 23,925 | 28,460 |
| TOTAL | $892,686 | $954,255 | $719,523 | $831,937 | $959,969 |
| Non-Current Assets | |||||
| PPE Net | 5,339 | 5,967 | 6,148 | 5,681 | 5,892 |
| Other Non-Current Assets | 17,553 | 18,647 | 34,546 | 35,274 | 36,637 |
| TOTAL | $22,892 | $24,614 | $40,694 | $40,955 | $42,529 |
| Total Assets | $915,578 | $978,869 | $760,217 | $872,892 | $1,002,498 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,500 | 31,494 | 37,342 | 14,099 | 16,220 |
| Accrued Expenses | 97,716 | 71,251 | 95,139 | 79,778 | 89,419 |
| Other current liabilities | 43,769 | 30,071 | 29,504 | 16,146 | 15,842 |
| TOTAL | $174,837 | $138,644 | $167,610 | $115,446 | $126,793 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 395,338 | 428,102 | 422,735 | 450,030 | 541,287 |
| TOTAL | $395,338 | $428,102 | $422,735 | $450,030 | $541,287 |
| Total Liabilities | $570,175 | $566,746 | $590,345 | $565,476 | $668,080 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,737 | 116,457 | 111,291 | 110,576 | 109,865 |
| Common Shares | 12 | 12 | 11 | 11 | 11 |
| Retained earnings | -2,608,675 | -2,486,638 | -2,308,860 | -2,142,869 | -1,951,600 |
| Other shareholders' equity | -796 | -775 | -875 | -3,027 | -3,194 |
| TOTAL | $345,403 | $412,123 | $169,872 | $307,416 | $334,418 |
| Total Liabilities And Equity | $915,578 | $978,869 | $760,217 | $872,892 | $1,002,498 |